Volume : 09, Issue : 05, May – 2022

Title:

53.DEVELOPMENT AND CHARACTERIZATION OF MUCOADHESIVE PATCHES OF BOSENTAN FOR BUCCAL ADMINISTRATION

Authors :

Mr. Tanveer.Y. Shaikh, Miss. Mrunal Shashikant Nhalade*, Dr.Bharat.V. Jain, Dr. Sandip.R. Pawar

Abstract :

Maximum of the preparations of anti-hypertensive drugs are presented within the market within the style of tablets. The disadvantage in terms of efficacy, absorption and bioavailability, undesirable side effects are because of fluctuating plasma drug level. Inability to keep up adequate drug concentrations in plasma for therapeutic effect, larger doses than those required by the cells should be administered so as to realize the therapeutic concentration. to beat all the shortcomings within the conventional tablet dosage forms, there’s a desire to formulate mucoadhesive buccal patches which provides an honest advantage of easy accessibility and needle free drug application without the need of a trained personnel facilitating self-medication.
KEYWORDS- Nanoparticles, Bosentan, HPMC K-100M.

Cite This Article:

Please cite this article in press Mrunal Shashikant Nhalade et al, Development And Characterization Of Mucoadhesive Patches Of Bosentan For Buccal Administration., Indo Am. J. P. Sci, 2022; 09(5).,

Number of Downloads : 10

References:

1. Nagai T, Nishimoto Y, Nambu N, Suzuki Y,Sekine K. 2000. Powder dosage forms of insulinfornasal administration. J Controlled Release 1, pp., 15–22.
2. William C. Cushman, George L. Bakris, William B. White, Michael A. Weber, Domenic Sica,Andrew Roberts, Eric Lloyd, Stuart Kupfer . 2012AzilsartanMedoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic Hypertension, Journal of American Heart Association pp: 310- 318.
3. Kathy Z., PharmD, Cheng W., PharmD, Azilsartan medoxomil: A New Angiotensin Receptor Blocker, Journal of Clinical Therapeutics, Volume 33, Number 11, pp., 1577-1588.
4. Kumar M, Prabhushankar GL, and Santhesh babu PR., 2010 Formulation and in-vitro evaluation of periodontal films containing metronidazole. Int J Pharm Tech Research volume2, no.4, pp., 2188-2193.
5. Mastiholimath VS, Dandagi PM, Gadad AP, Manvi FV, and Chandur VK.,2006Formulation and evaluation of Ornidazole dental implants for periodontitis. Indian Pharm sci volume68(1), pp,. 68‐ 71.
6. Silvia R, Giuseppina S, Carla MC.,2005 Buccal drug delivery A challenge already won Drug Discovery Today ,volume 2(1), pp., 59-65.
7. Semalty A, Semalty M, Singh R, Saraf SK, Saraf S., 2007 Properties and formulation of oral drug delivery systems of protein and peptides. Indian J Pharm Sci vol 6 pp; 741-7.
8. Gupta A, Garg S, Khar RK.,1994 Inter polymer complexation and its effect on bioadhesion strength and the solution characteristics of buccal drug delivery systems. Drug Dev Ind Pharm , volume 20; pp.,315-25
9. Sayani A, Chien Y.,1996 Systemic delivery of peptides and protein sacross absorptive mucosae, in: S.D. Bruck (Ed.), Critical Reviews in Therapeutic Drug Carrier System, 13, Begell House Inc, New York pp., 85–148
10. Oromucosal Preparations, European Directorate for the Quality of Medicines(EDQM), European Pharmacopoeia Commission in European Pharmacopoeia,7.4 ed., EDQM, Strasbourg, France, 2012. pp. 4257–4259.

11. PreisM, Woertz C, Kleinebudde P, Breitkreutz J 2013., Oromucosal film preparations: classification and characterization methods, Expert Opin. Drug Deliv.Volume10pp;1303–1317.
12. PadulaC, Colombo G, Nicoli S, Catellani P, Massimo G, Santi P.,2003Bioadhesivefilm for the transdermal delivery of lidocaine: in vitro and in vivo behavior, J. Control. Release volume 88, pp., 277–285.
13. Bhaskara J. and Xiaoling L. Gary C.,2004 Recent advances in mucoadhesive drug delivery systems. Business Briefing: Pharma tech pp., 194-196.
14. Wake WC.Theories of adhesion and uses of adhesive: a review. Polymer 1998volume19pp., 291–308
15. Khairnar A, Jain P, Baviskar D, Jain D,,2002 Development of mucoadhesive buccal patch containing aceclofenac: in-vitro evaluation. Int J Pharm Sci, , pp., 91-95.
16. Pednekar T, Pillai S.S, Shabaraya A.R, Azharuddin M. Design and, 2012 evaluation of buccal films of an antihypertensive drug. Am. J. Pharm Tech Res, pp., 711-722
17. Khanna R, Agrawal SP, Ahuja A.,1997 (Preparation and evaluation of buccal films ofcotrimazole for oral candida infections). Indian J Pharm Sci, pp.,299-305
18. Marina K, Narayana CR, Vijayanarayana K, Prabhu P., 2011In vitro and in vivo evaluation ofchitosan buccal films of ondanstron hydrochloride. Int J Pharm Investing, volume3pp.,64-171.
19. Samaligy EI, Yahia MS, Basalious A. F, 2004 design and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm, pp.,27-39
20. Mishra SK, Garud Navneet, Singh .,2011 Development and evaluation of mucoadhesive buccal patches of flurbiprofen. Acta Poloniae Pharmaceutical-Drug Research, pp., 955-964.
21. Vashmi Y, Chandrasekhar K, Ramesh G, Madhusudan Rao Y., 2004 Development of mucoadhesive patches for buccal administration of carvedilol. Curr Drug Deliv, pp.,2739.